SCHEMBL5084329

SCHEMBL5084329

Cc1ccc(C(=O)C=Cc2ccccc2O)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.71
MAPK1 P28482 1/20 0.71
CYP1B1 Q16678 1/20 0.63
ALDH1A1 P00352 5/20 0.62
ATM Q13315 3/20 0.62
RAB9A P51151 3/20 0.62
BCHE P06276 1/20 0.60
GUSB P08236 1/20 0.60
LMNA P02545 3/20 0.59
HPGD P15428 3/20 0.58
CYP3A4 P08684 2/20 0.58
PKM P14618 3/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
HTT P42858 2/20 0.58
NPSR1 Q6W5P4 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
NLRP1 Q9C000 1/20 0.58
NTSR1 P30989 1/20 0.58
TDP1 Q9NUW8 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5084324 1.00 MAPT (0.71) MAPTMAPK1CYP1B1ALDH1A1ATM
SCHEMBL5576960 0.86 MAPT (0.76) MAPTMAPK1CYP1B1RAB9ABCHE
SCHEMBL9250766 0.86 MAPT (0.76) MAPTMAPK1CYP1B1RAB9ABCHE
SCHEMBL626787 0.86 MAPT (0.75) MAPTMAPK1CYP1B1RAB9ABCHE
SCHEMBL10893208 0.86 MAPT (0.75) MAPTMAPK1CYP1B1RAB9ABCHE
SCHEMBL626785 0.86 MAPT (0.75) MAPTMAPK1CYP1B1RAB9ABCHE
SCHEMBL29420130 0.86 MAPT (0.75) MAPTMAPK1CYP1B1RAB9ABCHE
SCHEMBL10050575 0.85 CYP1B1 (0.65) MAPTMAPK1CYP1B1ALDH1A1ATM
Methane SCHEMBL728022 0.84 MAPT (0.73) MAPTMAPK1CYP1B1RAB9ABCHE
SCHEMBL3483671 0.83 MAPT (0.65) MAPTMAPK1ALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0428398-A2 Radiation-sensitive resin composition JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1991-05-22 EP claimed
US-4867964-A SUNSCREEN L'OREAL (FR) 1989-09-19 US claimed
CN-117624086-A Asymmetric synthesis method of oxetane under visible light catalysis 广西大学 2024-03-01 CN disclosed
WO-2007115181-A9 COMPOUNDS EXHIBITING EFFLUX INHIBITOR ACTIVITY AND COMPOSITIONS AND USES THEREOF EASTMAN CHEM CO (US) 2008-04-03 WO disclosed
WO-2007115181-A2 COMPOUNDS EXHIBITING EFFLUX INHIBITOR ACTIVITY AND COMPOSITIONS AND USES THEREOF EASTMAN CHEMICAL COMPANY (US) 2007-10-11 WO disclosed
US-20050090532-A1 Medicinal uses of dihydropyrazoles THE PROCTER & GAMBLE COMPANY 2005-04-28 US disclosed
US-6878729-B2 Medicinal uses of dihydropyrazoles THE PROCTER & GAMBLE COMPANY (US) 2005-04-12 US disclosed
US-20030083351-A1 Medicinal uses of dihydropyrazoles THE PROCTER & GAMBLE COMPANY 2003-05-01 US disclosed
US-4867964-A SUNSCREEN L'OREAL (FR) 1989-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050090532-A1 Medicinal uses of dihydropyrazoles EPOR, VEGFA, FLT4 MAPT 3229/4885MAPK1 3337/4885CYP1B1 831/4885
US-20030083351-A1 Medicinal uses of dihydropyrazoles EPOR, VEGFA, TEK MAPT 3317/4885MAPK1 2499/4885CYP1B1 554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.